Uncategorized
Pershing Square seeks to oust Allergan directors
Pershing Square Capital Management has requested a special meeting in an effort to oust a majority of the members of Allergan’s board of directors, according to a press release.During the meeting, Allergan stockholders would be asked to remove a majority of the company’s existing directors with ties to Valeant Pharmaceuticals and Pershing Square’s previous unsolicited proposal to acquire all outstanding shares of the company and request the appointment of new directors, according to the release.